Medtronic Operating Income 2010-2025 | MDT
Medtronic annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Medtronic operating income for the quarter ending April 30, 2025 was $1.435B, a 36.28% increase year-over-year.
- Medtronic operating income for the twelve months ending April 30, 2025 was $5.954B, a 15.72% increase year-over-year.
- Medtronic annual operating income for 2025 was $5.956B, a 15.76% increase from 2024.
- Medtronic annual operating income for 2024 was $5.145B, a 6.2% decline from 2023.
- Medtronic annual operating income for 2023 was $5.485B, a 4.66% decline from 2022.
| Medtronic Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $5,956 |
| 2024 | $5,145 |
| 2023 | $5,485 |
| 2022 | $5,753 |
| 2021 | $4,484 |
| 2020 | $4,791 |
| 2019 | $6,268 |
| 2018 | $6,640 |
| 2017 | $5,383 |
| 2016 | $5,361 |
| 2015 | $3,766 |
| 2014 | $3,813 |
| 2013 | $4,755 |
| 2012 | $4,748 |
| 2011 | $4,297 |
| 2010 | $4,714 |
| 2009 | $3,833 |
| Medtronic Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-04-30 | $1,435 |
| 2025-01-31 | $1,645 |
| 2024-10-31 | $1,594 |
| 2024-07-31 | $1,280 |
| 2024-04-30 | $1,053 |
| 2024-01-31 | $1,483 |
| 2023-10-31 | $1,340 |
| 2023-07-31 | $1,269 |
| 2023-04-30 | $1,567 |
| 2023-01-31 | $1,391 |
| 2022-10-31 | $1,403 |
| 2022-07-31 | $1,124 |
| 2022-04-30 | $1,672 |
| 2022-01-31 | $1,659 |
| 2021-10-31 | $1,563 |
| 2021-07-31 | $859 |
| 2021-04-30 | $1,604 |
| 2021-01-31 | $1,277 |
| 2020-10-31 | $930 |
| 2020-07-31 | $673 |
| 2020-04-30 | $316 |
| 2020-01-31 | $1,639 |
| 2019-10-31 | $1,351 |
| 2019-07-31 | $1,485 |
| 2019-04-30 | $1,946 |
| 2019-01-31 | $1,542 |
| 2018-10-31 | $1,544 |
| 2018-07-31 | $1,236 |
| 2018-04-30 | $1,928 |
| 2018-01-31 | $1,436 |
| 2017-10-31 | $1,894 |
| 2017-07-31 | $1,382 |
| 2017-04-30 | $1,684 |
| 2017-01-31 | $1,147 |
| 2016-10-31 | $1,385 |
| 2016-07-31 | $1,167 |
| 2016-04-30 | $1,575 |
| 2016-01-31 | $1,355 |
| 2015-10-31 | $1,300 |
| 2015-07-31 | $1,131 |
| 2015-04-30 | $159 |
| 2015-01-31 | $1,275 |
| 2014-10-31 | $1,193 |
| 2014-07-31 | $1,139 |
| 2014-04-30 | $305 |
| 2014-01-31 | $1,025 |
| 2013-10-31 | $1,206 |
| 2013-07-31 | $1,277 |
| 2013-04-30 | $1,191 |
| 2013-01-31 | $1,218 |
| 2012-10-31 | $1,186 |
| 2012-07-31 | $1,160 |
| 2012-04-30 | $1,215 |
| 2012-01-31 | $1,153 |
| 2011-10-31 | $1,221 |
| 2011-07-31 | $1,159 |
| 2011-04-30 | $982 |
| 2011-01-31 | $1,147 |
| 2010-10-31 | $1,089 |
| 2010-07-31 | $1,079 |
| 2010-04-30 | $1,056 |
| 2010-01-31 | $1,267 |
| 2009-10-31 | $1,224 |
| 2009-07-31 | $1,167 |
| 2009-04-30 | $660 |
| 2009-01-31 | $980 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $110.324B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |